Malnutrition and Cachexia — Clinical Documentation Guide (2026)

🔍 Definition

Malnutrition is a broad term encompassing deficiencies, excesses, or imbalances in a person's intake of energy and/or nutrients. In clinical coding, malnutrition most often refers to undernutrition — inadequate intake of protein, calories, or both — resulting in measurable physiological consequences. The American Society for Parenteral and Enteral Nutrition (ASPEN) and the American Academy of Nutrition and Dietetics (AND) jointly published consensus diagnostic criteria (the ASPEN/AND Consensus Statement, 2012, updated 2021) that define malnutrition by etiologic category and severity using observable clinical indicators including weight loss, energy intake, body composition, functional status, and inflammatory markers.

Malnutrition is classified in ICD-10-CM under categories E40–E46 and ranges from specified severe forms (E40 Kwashiorkor, E41 Nutritional marasmus) to unspecified protein-calorie malnutrition (E46). Severity coding is critical: the difference between E44.1 (mild) and E43 (severe) represents the difference between no risk adjustment credit and HCC 48 with a RAF weight of approximately 1.018 — a difference worth $1,500–$3,000+ in annual per-member revenue under CMS-HCC Model v28.

Cachexia (ICD-10-CM R64) is a complex metabolic syndrome associated with underlying chronic illness and characterized by loss of muscle (with or without fat mass), elevated inflammatory markers, anorexia, and functional decline. Unlike starvation-related malnutrition, cachexia is driven by an inflammatory response and is not fully reversible with nutritional supplementation alone. Cachexia must be linked to a documented underlying disease — neoplastic, cardiac, pulmonary, renal, or infectious — to be coded properly. R64 maps to HCC 48 in v28.

Sarcopenia (M62.84, FY2024 new code, active in FY2026) is defined as age-related progressive loss of skeletal muscle mass and function. While sarcopenia often coexists with malnutrition and cachexia, it does not map to an HCC and is primarily used for geriatric coding and quality metrics.

🗂️ Alternative Terminology

Clinicians and dietitians use a wide variety of terms for these conditions. Coders and CDI specialists must recognize all of them and map appropriately to ICD-10-CM codes.

🩺 Signs & Symptoms

The ASPEN/AND consensus criteria identify six clinical characteristics used to diagnose and grade malnutrition. At least two must be present for diagnosis:

1. Insufficient energy intake — documented reduction in intake relative to estimated needs
2. Weight loss — measured or reported over defined timeframe
3. Loss of muscle mass — assessed by physical examination, DEXA, or validated tools (SGA, MNA)
4. Loss of subcutaneous fat — orbital, triceps, chest wall wasting on physical exam
5. Localized or generalized fluid accumulation — may mask true weight loss (edema in kwashiorkor)
6. Diminished functional status — reduced grip strength, declining performance status

Additional clinical indicators by severity:

Cachexia-specific findings: involuntary weight loss >5% in 12 months (or BMI <20) plus ≥3 of the following: decreased muscle strength, fatigue, anorexia, low fat-free mass index, elevated inflammatory markers (CRP >5 mg/L, IL-6 >4 pg/mL), anemia, low serum albumin (<3.2 g/dL). Per the 2011 international consensus definition, cachexia has three stages: pre-cachexia, cachexia, and refractory cachexia.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

Documentation of malnutrition must meet ICD-10-CM Official Guidelines Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases). The diagnosis must be documented by a physician or qualified provider — dietitian documentation may support the query but cannot stand alone for coding purposes unless the facility has an approved dietitian scope-of-practice policy. The provider must authenticate (sign or co-sign) a malnutrition diagnosis.

🦴 Anatomy & Pathophysiology

Protein-calorie malnutrition (PCM) develops when energy and/or protein intake chronically fails to meet metabolic demand. The body initially mobilizes glycogen stores, then fat (lipolysis), and finally catabolizes skeletal muscle protein (gluconeogenesis) to maintain vital organ function. Progressive muscle wasting (sarcopenia-like) ensues, accompanied by immune suppression, impaired wound healing, endocrine dysregulation, and multiorgan dysfunction.

Two major PCM phenotypes:

• Marasmus (E41): Predominant caloric deficiency. Body adapts via profound fat and muscle catabolism but maintains serum albumin relatively. Patient appears severely emaciated — "skin and bones." Low BMI, sunken cheeks, temporal wasting, no edema. Common in chronic starvation, advanced cancer, prolonged NPO states.
• Kwashiorkor (E40): Predominant protein deficiency with relatively adequate caloric intake. Hypoalbuminemia drives oncotic pressure loss → pitting edema, ascites, anasarca. Skin changes (flaky paint dermatosis), hair changes (flag sign — alternating light/dark bands). Patient may appear "well-nourished" due to edema masking weight loss. More common in hospitalized patients on glucose-only fluids.

Cachexia pathophysiology: Driven by pro-inflammatory cytokines — TNF-α, IL-1β, IL-6, IFN-γ — released by the underlying disease (tumor, failing heart, inflamed lung). These cytokines activate ubiquitin-proteasome pathways in skeletal muscle, causing accelerated proteolysis. Unlike starvation, cachexia involves both muscle protein breakdown and impaired anabolism — feeding does not reverse it. The result is disproportionate loss of lean body mass with relative preservation of fat (or simultaneous fat loss in refractory cachexia). Loss of lean mass directly correlates with functional decline, treatment toxicity in cancer, and mortality.

Vitamin deficiencies arise when dietary intake, absorption, or metabolic conversion of specific micronutrients is insufficient. Each deficiency syndrome has a distinct pathophysiology: thiamine (E51) affects cellular energy metabolism; niacin (E52/pellagra) affects NAD+-dependent reactions; vitamin C (E54) impairs collagen cross-linking; vitamin D (E55) disrupts calcium homeostasis and bone mineralization; vitamin K (E56.1) impairs coagulation factor carboxylation.

💊 Medication Impact / Treatment

Several medications influence nutritional status and are relevant to malnutrition/cachexia coding and CDI:

• Corticosteroids: Chronic use causes muscle catabolism, fat redistribution, glucose intolerance, and bone loss — can mask malnutrition or cause steroid-induced myopathy. Document steroid-induced osteoporosis (M81.6) separately if applicable.
• Chemotherapy: Causes mucositis, nausea, anorexia, malabsorption — major driver of cancer cachexia. CDI opportunity: document cachexia (R64 + neoplasm code) when meeting criteria.
• Immunosuppressants (tacrolimus, mycophenolate): GI side effects reduce intake; monitor prealbumin, albumin.
• Diuretics: May deplete potassium, magnesium, and zinc; mask edematous malnutrition in fluid-overloaded patients.
• Proton pump inhibitors (long-term): Reduce vitamin B12 absorption; code E53.8 if deficiency documented.
• Metformin (long-term): Associated with B12 malabsorption — code E53.8 or use drug-induced nutritional deficiency coding.
• Orexigenic agents: Megestrol acetate, dronabinol — used to stimulate appetite in cachexia; do not reverse the underlying inflammatory process.
• Cyanocobalamin (vitamin B12): Administered by injection (J3420, 96372) or oral supplementation for deficiency states (E53.8).
• Vitamin D supplements: Oral calcitriol or ergocalciferol for E55.x deficiencies; IV calcitriol in dialysis patients.
• Parenteral/enteral nutrition (TPN/EN): Primary treatment for severe malnutrition when oral intake is inadequate or impossible. Document indication (malnutrition code) and route (Z93.1 gastrostomy status, Z99.89 dependence).

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides